Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth. [electronic resource] by
- Ma, Xun
- Wong, Sandy W
- Zhou, Ping
- Chaulagain, Chakra P
- Doshi, Parul
- Klein, Andreas K
- Sprague, Kellie
- Kugelmass, Adin
- Toskic, Denis
- Warner, Melissa
- Miller, Kenneth B
- Lee, Lisa
- Varga, Cindy
- Comenzo, Raymond L
Publication details: Experimental hematology & oncology 2018
In:
Experimental hematology & oncology vol. 7
Availability: No items available.
|